Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.8 |